391 related articles for article (PubMed ID: 25426779)
41. Recent advances of cocktail chemotherapy by combination drug delivery systems.
Hu Q; Sun W; Wang C; Gu Z
Adv Drug Deliv Rev; 2016 Mar; 98():19-34. PubMed ID: 26546751
[TBL] [Abstract][Full Text] [Related]
42. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
Devalapally H; Duan Z; Seiden MV; Amiji MM
Clin Cancer Res; 2008 May; 14(10):3193-203. PubMed ID: 18483388
[TBL] [Abstract][Full Text] [Related]
43. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
44. A Nanoparticle Cocktail: Temporal Release of Predefined Drug Combinations.
Pathak RK; Dhar S
J Am Chem Soc; 2015 Jul; 137(26):8324-7. PubMed ID: 26086212
[TBL] [Abstract][Full Text] [Related]
45. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
46. Theranostic nanomedicine for cancer.
Sumer B; Gao J
Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
[No Abstract] [Full Text] [Related]
47. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
Cadete A; Alonso MJ
Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
[TBL] [Abstract][Full Text] [Related]
48. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
49. Nanomedicines for the Treatment of CNS Diseases.
Reynolds JL; Mahato RI
J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
[TBL] [Abstract][Full Text] [Related]
50. Can a nanoparticle that mimics Salmonella effectively combat tumor chemotherapy resistance?
Mercado-Lubo R; McCormick BA
Nanomedicine (Lond); 2017 Apr; 12(7):705-710. PubMed ID: 28322607
[No Abstract] [Full Text] [Related]
51. Nanooncology: the future of cancer diagnosis and therapy.
Thakor AS; Gambhir SS
CA Cancer J Clin; 2013; 63(6):395-418. PubMed ID: 24114523
[TBL] [Abstract][Full Text] [Related]
52. Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers.
Dawar S; Singh N; Kanwar RK; Kennedy RL; Veedu RN; Zhou SF; Krishnakumar S; Hazra S; Sasidharan S; Duan W; Kanwar JR
Drug Discov Today; 2013 Dec; 18(23-24):1292-300. PubMed ID: 24055842
[TBL] [Abstract][Full Text] [Related]
53. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
Jeong K; Kang CS; Kim Y; Lee YD; Kwon IC; Kim S
Cancer Lett; 2016 Apr; 374(1):31-43. PubMed ID: 26854717
[TBL] [Abstract][Full Text] [Related]
54. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
55. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
Panzarini E; Dini L
Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
[TBL] [Abstract][Full Text] [Related]
56. Recent advances in nanooncology.
Jain KK
Technol Cancer Res Treat; 2008 Feb; 7(1):1-13. PubMed ID: 18198919
[TBL] [Abstract][Full Text] [Related]
57. Gold nanoparticles: emerging paradigm for targeted drug delivery system.
Kumar A; Zhang X; Liang XJ
Biotechnol Adv; 2013; 31(5):593-606. PubMed ID: 23111203
[TBL] [Abstract][Full Text] [Related]
58. Nanoparticle technologies for cancer therapy.
Alexis F; Pridgen EM; Langer R; Farokhzad OC
Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
[TBL] [Abstract][Full Text] [Related]
59. Nanoparticle-based polychemotherapy: optimizing drug synergy for efficacious cancer treatment.
Blanco E
Ther Deliv; 2014 Jul; 5(7):737-9. PubMed ID: 25287379
[No Abstract] [Full Text] [Related]
60. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
